ESC Premium Access

Comparison of the low-density lipoprotein cholesterol target value and the preventive effect of statins in elderly patients and younger patients

Congress Presentation

About the speaker

Doctor Akihiro Endo

Shimane University Faculty of Medicine, Izumo (Japan)
0 follower

4 more presentations in this session

State of the Art: cholesterol-lowering therapy for primary and secondary prevention

Speaker: Doctor J. Robinson (Iowa, US)


Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes mellitus: a systematic review and meta-analysis with over 10,000 patients

Speaker: Doctor L. Carvalho (Brasilia, BR)


Effect of the magnitude of LDL lowering on the incidence of cataract among patients treated with statins or PCSK9 antibodies

Speaker: Doctor J. Kostis (New Brunswick, US)


Lipid-lowering therapy in primary prevention: where will we be 10 years from now

Speaker: Professor A. Catapano (Milan, IT)


Access the full session

Cholesterol-lowering therapy for primary and secondary prevention

Speakers: Doctor A. Endo, Doctor J. Robinson, Doctor L. Carvalho, Doctor J. Kostis, Professor A. Catapano

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb